b'Precision Medicine Assays Detect Novel Targetable FLT3 FusionsSomatic Hypermutation and V-J Gene Usage for CLL Prognosis: Amenable to Therapeutic Intervention in a Patient with RefractoryEvaluating Data from MiSeq NGS vs. PCR-Sanger Sequencing Acute Myeloid LeukemiaApproaches Poster Presented at: 58th Annual American Society for HematologyPoster Presented at: 56th Annual American Society for Hematology Meeting. 2016 Dec. 3-6. San Diego, CA, USA.Meeting. 2014 Dec. 6-9. San Francisco, CA, USA.Next-Generation Sequencing of FLT3/ITD for Minimal ResidualInternational Validation of a Harmonized NGS PGM Assay at Clinical Disease Monitoring in Leukemia PatientsLabs in the US and the EU Poster Presented at: Association for Molecular Pathology 2016 AnnualPoster Presented at: Association for Molecular Pathology 2014 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center inMeeting. 2014 Nov 13-15. National Harbor, MD, USA. Charlotte, NC, USA.Performance of an IGH Somatic Hypermutation Assay withNext-Generation Sequencing of NPM1 for Minimal Residual DiseaseAssociated LymphoTrack Bioinformatics Developed for the MiSeq Monitoring in Leukemia Patients NGS Platform Poster Presented at: Association for Molecular Pathology 2016 AnnualPoster Presented at: 19th Congress of the European Hematology Meeting. November 10-12, 2016 at the Charlotte Convention Center inAssociation. 2014 June 12-15. Milan, Italy. Charlotte, NC, USA.Concordance in IGH & TRG Clonality Testing: Comparison of Data Detection of Clonal Immunoglobulin and T-Cell Receptor GeneGenerated Using the MiSeq & PGM TMPlatformsRearrangements in Acute Myeloid LeukemiaPoster Presented at: 19th Congress of the European Hematology Poster Presented at: Association for Molecular Pathology 2016 AnnualAssociation. 2014 June 12-15. Milan, Italy. Meeting. November 10-12, 2016 at the Charlotte Convention Center in Charlotte, NC, USA. Combined TRG and IGH Clonality Testing on the PGM TMUsing LymphoTrack Reagents & BioinformaticsDevelopment of a Comprehensive IGH NGS Assay for DetectingPoster Presented at: 19th Congress of the European Hematology Suspected B-Cell ClonalityAssociation. 2014 June 12-15. Milan, Italy.Poster Presented at: Association for Molecular Pathology 2016 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center inIdentifying and Monitoring IGH Clonality Using Massively Parallel Charlotte, NC, USA. Sequencing and Associated Bioinformatics Poster Presented at: Association for Molecular Pathology 2013 Annual Detection of Minimal Residual Disease in FLT3/ITD AMLMeeting. 2013 Nov. 15-16. Phoenix, AZ, USA. Poster presented at: American Society of Clinical Oncology 2016 Annual Meeting. June 3-7, 2016 at McCormick Place in Chicago, Illinois, USA. Detecting Minimal Residual Disease Using a Massively Parallel Sequencing TCRG AssayDevelopment of LymphoTrack Bioinformatics Methods: ClonalityPoster Presented at: Association for Molecular Pathology 2013 Annual Testing, Somatic Hypermutation, and Minimal Residual Disease Meeting. 2013 Nov. 15-16. Phoenix, AZ, USA. Poster Presented at: Association for Molecular Pathology 2015 Annual Meeting. 2015 Nov 4-8. Austin, TX, USA. Identifying and Monitoring TCRG Clonality Using Massively Parallel Sequencing and Associated BioinformaticsDetection of Clonal TRG Gene Rearrangements Shows ImprovedPoster Presented at: 18th Congress of the European Hematology Sensitivity and Positive Predictive Value Compared to FragmentAssociation. 2013 June 13-16. Stockholm, Sweden. Analysis Using BIOMED-2 Primers and Capillary ElectrophoresisPoster Presented at: Association for Molecular Pathology 2015 Annual Meeting. 2015 Nov 4-8. Austin, TX, USA.Development of an NGS Assay for IGK that can be Combined with IGH for Identifying Clonal Populations in Lymphoid MalignanciesPoster Presented at: 20th Congress of the European Hematology Association. 2015 June 11-14. Vienna, Austria.Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing Poster Presented at: 20th Congress of the European Hematology Association. 2015 June 11-14. Vienna, Austria.Invivoscribe 2020|163'